Items tagged with Treatment
Drug resistance patterns of drug-resistant TB in Korea (post)
Additional drug resistance patterns among multidrug-resistant TB patients in Korea: implications for regimen design
STREAM community engagement workshop held in Tbilisi, Georgia (post)
The STREAM trial, which is evaluating the effectiveness of shorter treatment regimens for multidrug-resistant tuberculosis (MDR-TB), held a community engagement workshop in Tblisi, Georgia, where the Stage 2 trial is planned to initiate shortly. Stage 2 will study a six-month MDR-TB treatment and a nine-month all oral regimen.
Spero Therapeutics receives grant from National Institutes of Health to explore novel treatment combinations for TB (post)
CAMBRIDGE, Mass., May 4, 2017—Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced that it has received a grant from the National Institutes of Health (NIH) to conduct additional preclinical studies of SPR720, the Company’s novel oral bacterial gyrase inhibitor, for the treatment of tuberculosis (TB). The non-dilutive grant of $564,718 is part of the NIH’s Small Business Innovation Research (SBIR) program (Grant Number: 1R44AI131749-01).
Ibrutinib may inhibit macrophage response to TB (post)
Ibrutinib may inhibit the macrophage-mediate response to Mycobacterium tuberculosis (Mtb) among patients with chronic lymphocytic leukemia (CLL), according to an abstract presented at the XVII International Workshop on Chronic Lymphocytic Leukemia (iwCLL).1
Later-generation fluoroquinolones more effective at reducing mortality risk in resistant TB (post)
Later-generation fluoroquinolones significantly reduced the risk for mortality in patients with suspected drug-resistant tuberculosis compared with early-generation drugs of the same family, according to researchers.
Child-friendly TB tablets to be introduced in India (post)
There is good news for children suffering from tuberculosis as the government has started the rollout of the world's first easily-dissolvable and flavoured drug in five states as part of a pilot programme.
ITPCru poster: TB treatment (post)
ITPCru has developed a poster on TB treatment. It is based on the World Health Organization (WHO) guidelines 2010 with taking into account the April 2017 updates.
Directly observed therapy for multidrug-resistant TB decreases mortality (post)
ATS 2017, WASHINGTON, DC ─ Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR-TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference.
Population implications of the use of bedaquiline in people with extensively drug-resistant TB: are fears of resistance justified? (post)
Summary
Readily available antibiotic could help to curb lung damage from TB (post)
Imperial scientists have found how a common antibiotic could help reduce lung destruction in people with Tuberculosis (TB).
Page 31 of 108 · Total posts: 0
←First 30 31 32 Last→